Tag: cSDH
Onyx gains US indication for MMA embolisation in chronic subdural haematoma...
Medtronic announced this week that its Onyx liquid embolic system is now indicated for embolisation of the middle meningeal artery (MMA)—as a surgical adjunct—to...
Procedural choices matter but vascular penetration has minimal impact on MMAe...
Sub-analyses of two randomised controlled trials (RCTs) have found that, while the extent of vascular penetration appears to have a minimal bearing on outcomes,...
SwiftPAC opens door for standalone coiling in MMA embolisation procedures
NOTE: This video is ONLY available to watch in selected countries and geographies
With his interest in the endovascular treatment of chronic subdural haematoma...
SwiftPAC coil set to create new possibilities in MMA embolisation
This advertorial, intended only for audiences outside the USA, is sponsored by Penumbra.
Following its CE-mark approval and European commercial launch in September this year,...
Weighing up particles, EVOH-based liquid agents and glues in MMA embolisation
With the technique of middle meningeal artery embolisation (MMAe) presently coming of age in chronic subdural haematoma (cSDH) management, Franziska Dorn (Bonn, Germany) outlines...
Canadian RCT joins growing list of studies demonstrating benefits with MMA embolisation...
The findings of EMMA-CAN—the first randomised controlled trial (RCT) in Canada assessing embolisation of the middle meningeal artery (EMMA) as an adjunct to surgical...
Microparticle-based MMAe effect size “consistent with other trials” despite failure to...
Middle meningeal artery embolisation (MMAe) involving microparticles—as opposed to liquid embolic agents, glues or coils—did not lead to a statistically significant reduction in six-month...
Penumbra receives European CE mark for SwiftPAC neuroembolisation coils
Penumbra has secured CE-mark approval for its SwiftPAC neuroembolisation coil, which is part of the company’s Swift coil system. SwiftPAC coils are now commercially...
EMBO-02 study indicates rapid cSDH resorption and pain-free treatments with NeoCast...
Arsenal Medical has announced late-breaking data from the EMBO-02 clinical study evaluating NeoCast—a next-generation, shear-responsive liquid embolic agent—in the treatment of patients with chronic...
Single-session MMA embolisation and surgical evacuation could enable more “resource-efficient” cSDH...
Performing a middle meningeal artery (MMA) embolisation procedure during the same anaesthesia session as a burr hole evacuation surgery represents a safe and potentially...
Arsenal Medical completes enrolment of initial EMBO-02 study cohort
Arsenal Medical has announced the complete enrolment of an initial cohort of 10 patients in the EMBO-02 clinical study evaluating NeoCast for the treatment...
Combined embolisation-drainage approach could be “transformational” next step in endovascular cSDH...
The past 18 months have seen a radical shift in clinical evidence supporting the role of middle meningeal artery embolisation (MMAe) within subdural haematoma...
MEMBRANE becomes latest RCT to demonstrate MMA embolisation’s benefits in cSDH...
The MEMBRANE randomised controlled trial (RCT)—presented at the 2024 Society of Vascular and Interventional Neurology (SVIN) annual meeting (20–22 November, San Diego, USA) by...
Landmark MMA embolisation trials published in New England Journal of Medicine
Detailed results from three randomised controlled trials (RCTs) evaluating middle meningeal artery (MMA) embolisation in the treatment of chronic subdural haematoma (cSDH) have been...
Arsenal Medical launches EMBO-02 study to assess NeoCast in cSDH treatment
Arsenal Medical today announced the initiation of the EMBO-02 clinical study of NeoCast in the treatment of chronic subdural haematomas (cSDHs). NeoCast is a...
Recent breakthroughs in cSDH intervention may lead to “HERMES-style collaborative”
Following their initial presentation earlier this year, two randomised controlled trials (RCTs) indicating positive outcomes with middle meningeal artery (MMA) embolisation in chronic subdural...
ARISE I recommends multidisciplinary approach to managing brain aneurysms, chronic SDHs...
Three papers published in the journal Stroke have highlighted multidisciplinary care and global, collaborative efforts as “paramount” in the management of intracranial aneurysms, chronic...
